RPL30

Large ribosomal subunit protein eL30 · P62888 · RPL30 on Sugi Atlas →

0 patent compounds predicted against RPL30, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL30 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer PHASE1/PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery PHASE1COMPLETED
Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma PHASE1COMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
RibOSE - Glucose and Resistance Exercise Training nanCOMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease. nanRECRUITING
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) nanACTIVE_NOT_RECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Steroid Treatment of Idiopathic Nephrotic Syndrome nanCOMPLETED
Exercise on Expression of Heat Shock Protein 70 in Arterial Risk nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RPL30 binder may also engage these)

ProteinNameSimilarity
P62889 1.000 P62889 →
Q76KA2 1.000 Q76KA2 →
Q3T0D5 1.000 Q3T0D5 →
P62890 1.000 P62890 →
P67884 1.000 P67884 →
P67883 1.000 P67883 →
P58375 1.000 P58375 →
G1TDL2 1.000 G1TDL2 →
P58372 1.000 P58372 →
P58374 0.998 P58374 →
Q9M5M6 0.993 Q9M5M6 →
P0DJ59 0.991 P0DJ59 →
Q8VZ19 0.991 Q8VZ19 →
P52808 0.990 P52808 →
Q55BS9 0.989 Q55BS9 →
O49884 0.988 O49884 →
Q7S7F1 0.988 Q7S7F1 →
Q9LSA3 0.988 Q9LSA3 →
Q6C4U7 0.987 Q6C4U7 →
A4FWF4 0.987 A4FWF4 →
P14120 0.987 P14120 →
Q6LXI6 0.986 Q6LXI6 →
Q9C8F7 0.986 Q9C8F7 →
Q752U5 0.986 Q752U5 →
A0A1D8PM75 0.985 A0A1D8PM75 →
P49153 0.984 P49153 →
P14025 0.984 P14025 →
Q6FXZ0 0.984 Q6FXZ0 →
Q9UTP0 0.984 Q9UTP0 →
P39095 0.984 P39095 →